Indian Stocks signal
TORNTPHARM

TORNTPHARM

Torrent Pharmaceuticals Limited · Healthcare

Indian StocksDrug Manufacturers - Specialty & GenericNSIINR-10.5% from ATH
Current Price

$4,584.10

Drawdown from ATH

-10.5%

Last Updated

Oct 16, 2026

Dipsern Grade90d

D

Weak

Graded against TORNTPHARM's own history at this drawdown — not the market's.

What it means: TORNTPHARM's own history does not strongly favor buying at this level yet.

What to do: Consider watching and waiting for a deeper dip or a higher grade.

Median 90-Day Return
Historical Win Rate
Last 30 days-0.84%
Oct 1Nov 12
About TORNTPHARM

Torrent Pharmaceuticals Limited

Torrent Pharmaceuticals Limited engages in the research, development, manufacturing, marketing, and distribution of branded and generic pharmaceutical formulations in India, the United States, Brazil, Germany, and internationally. The company offers products in various therapeutic areas, including anti-diabetic, anti-microbial, cardiovascular, urology, gynecology, oncology, gastro-intestinal, nephrology, neuro-psychiatric, cosmo-dermatology, pain management, anti-infective, and miscellaneous, as

The reading

How Dipsern reads TORNTPHARM right now.

Three plain-English paragraphs — current state, historical base rate, and interpretation — so you walk away with context, not a dashboard.

Snapshot

How is TORNTPHARM doing right now?

In plain terms: TORNTPHARM is 10.5% below its highest-ever price. Dipsern checks every past time it was this far down and grades how the next 90 days usually went.

Torrent Pharmaceuticals Ltd. (TORNTPHARM) sits 10.5% off its peak and is currently in a moderate correction, last printing at $4,584.1. A drawdown of this depth is where patient buyers start paying attention. Historically the asymmetry begins to favor accumulation here, especially when paired with structural demand.

Historical base rate

What history says at this drawdown

History at this drawdown level is well-populated for TORNTPHARM — 746 confirmed observations in the 15%-to-10% band. The Dipsern engine uses these to compute a rolling median rather than a mean, because medians are robust to the kind of fat tails you find in indian stocks return distributions. The win rate (% of episodes that closed positive after 90 days) is shown in the segments table below.

Interpretation

What this means for TORNTPHARM

Drawdown-based signals work across asset classes but the magnitude of meaningful moves varies. Dipsern computes the segmentation per-asset so the bands are calibrated to TORNTPHARM's own volatility history. Moderate corrections are the highest-information zone for the Dipsern signal: enough drawdown for mean-reversion to matter, not so much that fundamentals are likely broken. Watch the prediction-error column — if past signals at this level were accurate, the current one is more trustworthy.

Comparable signals

Other Indian Stocks at similar drawdown levels

Five tickers closest to TORNTPHARM's distance from all-time high. Same category, one tap away.

JSW Steel Ltd.

-10.5% from ATH

Bosch Ltd.

-9.9% from ATH

Zydus Lifesciences Ltd.

-11.3% from ATH

Solar Industries India Ltd.

-11.5% from ATH

Pidilite Industries Ltd.

-11.5% from ATH

Historical depth

Sample sizes by drawdown band

Dipsern segments the full drawdown range into 20 equal-width bands. The table shows the number of confirmed historical observations in each band for TORNTPHARM. Median forward returns, win rates, and prediction errors are available in the full analysis.

Drawdown BandObservationsMedian ReturnWin Rate
-60% to -55%8
-55% to -50%81
-50% to -45%69
-45% to -40%103
-40% to -35%65
-35% to -30%209
-30% to -25%313
-25% to -20%508
-20% to -15%587
-15% to -10%Current746
-10% to -5%1267
-5% to 0%2018
Methodology

Every grade is reproducible.

We segment 40+ years of TORNTPHARM's price history into 20 equal-width drawdown bands and compute forward median returns, win rates, and prediction error per band. No look-ahead bias. Pure NumPy. Open math, gated numbers.

Years of history

40+

Drawdown bands

20

Look-ahead bias

None

Data sources

4

Unlock TORNTPHARM's full analysis

See the Dipsern grade, median returns, win rates, prediction accuracy, 8 interactive charts, historical price paths, and a plain-English verdict for TORNTPHARM.

Dipsern is research and a second opinion — not a broker. You'd buy TORNTPHARM at your own broker.

Analyze TORNTPHARM Free

No credit card required · 5 free analyses per month

Signal computed Oct 16, 2026 using default parameters (90-day return period, 20 segments, 0.95 decay). Data sourced from Yahoo Finance, Binance, CoinGecko, and Steam Market.